Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NAAA | Q02083 | 2/20 | 0.53 |
| ▸ | P2RX7 | Q99572 | 1/20 | 0.47 |
| ▸ | HDAC3 | O15379 | 5/20 | 0.43 |
| ▸ | LMNA | P02545 | 2/20 | 0.41 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.41 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.41 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.41 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.41 |
| ▸ | MEN1 | O00255 | 1/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.41 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.41 |
| ▸ | MAPT | P10636 | 1/20 | 0.41 |
| ▸ | HTT | P42858 | 1/20 | 0.41 |
| ▸ | RAB9A | P51151 | 1/20 | 0.41 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.41 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.41 |
| ▸ | HDAC1 | Q13547 | 2/20 | 0.41 |
| ▸ | HDAC2 | Q92769 | 2/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.40 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL668809 | 0.95 | P2RX7 (0.49) | NAAAP2RX7HDAC3LMNACYP1A2 | |
| SCHEMBL668810 | 0.81 | P2RX7 (0.50) | P2RX7HDAC3LMNARAB9AHDAC1 | |
| SCHEMBL20216434 | 0.71 | NAAA (1.00) | NAAAHDAC3HTTRAB9ASMN1; SMN2 | |
| SCHEMBL8204741 | 0.71 | NAAA (1.00) | NAAAHDAC3HTTRAB9ASMN1; SMN2 | |
| SCHEMBL1002638 | 0.71 | NAAA (1.00) | NAAAHDAC3HTTRAB9ASMN1; SMN2 | |
| SCHEMBL1003239 | 0.71 | NAAA (1.00) | NAAAHDAC3HTTRAB9ASMN1; SMN2 | |
| SCHEMBL1002305 | 0.71 | NAAA (1.00) | NAAAHDAC3HTTRAB9ASMN1; SMN2 | |
| SCHEMBL421014 | 0.71 | NAAA (1.00) | NAAAHDAC3HTTRAB9ASMN1; SMN2 | |
| SCHEMBL1004555 | 0.71 | NAAA (1.00) | NAAAHDAC3HTTRAB9ASMN1; SMN2 | |
| SCHEMBL28927370 | 0.71 | NAAA (1.00) | NAAAHDAC3HTTRAB9ASMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20120046455-A1 | Catalytic Cyclopropanation of Alkenes with Alpha-Cyano-Diazoacetates | NATIONAL SCIENCE FOUNDATION | 2012-02-23 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120046455-A1 | Catalytic Cyclopropanation of Alkenes with Alpha-Cyano-Diazoacetates | PPOX, POR, PCCA | NAAA 358/4885P2RX7 4266/4885HDAC3 3764/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.